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S U M M A R Y
T h e  role o f  T -c e lls  in d ev e lo pm en t o f  ex perim en ta l ce reb ra l m a la r ia  w as an a ly sed  in  C 5 7 B 1 /6 J  a n d  C 5 7 B l /1 0 m ic e  in fe c te d  
w ith  Plasm odium  berghei K 173 or Plasmodium berghei A N K A  b y  t r e a tm e n t  w ith  a n t i - C D 4  o r  a n t i - C D 8 m A b s .  M ic e  w e re  
p ro tec ted  against cerebra l m alaria  (C M ) w hen  a n t i -C D 4  o r  a n t i - C D 8  m A b s  w e re  in je c te d  b e fo re  o r  d u r in g  in fec tio n . E v e n  
in m ice in en d -s tag e  disease, i.e. w ith  a body  te m p e ra tu re  b e lo w  35-5 °C , t r e a tm e n t  w i th  a n t i - C D 4  o r  a n t i - C D 8 a n t ib o d ie s  
or th e  co m b in a tio n  p ro tec ted  against C M , w h e rea s  c h lo ro q u in e  t r e a tm e n t  w as  c o m p le te ly  in e ffec tive  in in h ib i t in g  f u r th e r  
d ev e lo p m en t of th e  cerebra l syndrom e.
K e y  w o rd s : Plasm odium  berghei, cerebral m ala ria , p ro tec tio n , C D 4 , C D 8 , b lo o d - b r a in  b a r r ie r .
I N T R O D U C T I O N
There are a number of rodent models available for 
the study of the pathogenesis of experimental 
cerebral malaria. In these studies mice (Rest, 1982; 
Grau et ah 1986; Thumwood et ah 1988; Curfs et ah  
1989), rats (Wright, Masemble & Bazira, 1971) and 
hamsters (Rest & Wright, 1979) were used in 
combination with different strains of P. berghei 
parasites, e.g. ANKA (Grau et al. 1986) or K173 
(Curfs et al. 1989).
In all these models an immunopathological re­
action is considered to be involved in the de­
is prevented by CD8+ T-cell depletion, but not by 
CD4+ T-cell depletion. In our model (P . berghei 
K173, C57B1 mice) Curfs et al. (1989) confirmed a 
role for T-cells in the development of experimental 
cerebral malaria since nude mice, thymectomized 
mice and mice treated with an anti-T-cell serum 
were protected against cerebral malaria.
Here, we describe the results of treatment with 
anti-CD4 and anti-CD8 antibodies in P. berghei 
ANKA- and K173-infected C57B1 mice. The results 
show that treatment with anti-CD4 or anti-CD8 
antibodies can prevent development of experimental 
cerebral malaria. Moreover, even when performed
velopment of the syndrome. Studies in rodent shortly before expected death, i.e. in end-stage
models showed sequestration and adherence of white 
blood cells to the endothelial lining of post-capillary 
venules in the brains in association with development 
of petechiae (Rest, 1982; Polder et ah 1992).
In the model described by Grau et ah (1986)
(P. berghei ANKA, CBA/Ca mice), CD4+ T-cells 
play an important role since depletion of CD4+ T~ 
cells prevents, and transfer of CD4+ T-cells from 
mice developing cerebral malaria enhances, devel­
opment of the cerebral syndrome. In addition, 
depletion of CD8+ T-cells did not prevent cerebral 
malaria. In mice with Murine Acquired Immuno­
deficiency Syndrome (MAIDS), which is character­
ized by abnormal functioning of CD4+ T-cells the 
level of protection against murine CM is significantly 
increased and is related to the duration of the viral 
infection and, hence, with the severity of CD4+ T- 
cell immunodeficiency (Eckwalanga et ah 1994). In P arasite
disease when body temperature has decreased to
35*5 °C or lower, depletion of CD4 or CD8 T-cells
effectively prevented further development of the 
cerebral syndrome.
M A T E R I A L S  A N D  M E T H O D S
M ice
C57Black/6J or C57Black/10 mice, aged 6-10 weeks,
were obtained from specific pathogen-free colonies 
maintained at the Central Animal Facility of the 
University of Nijmegen. All mice were housed in 
plastic cages and received water and standard RMH 
food (Hope Farms, Woerden, The Netherlands) a d  
lib itum .
the model using WM/Ms rats and P. berghei NK65 
parasites (Imai & Kamiyama, 1994) cerebral malaria
* C o rre sp o n d in g  au tho r. T e l :  -f 31 24 3614664, F a x :  + 3 1
24 3540216. E -m a il :  r .h e rm se n @ m m b .a z n .n l
Plasmodium berghei K173 and Plasm odium  berghei 
ANKA were maintained by weekly transfer of 
parasitized erythrocytes (PE) from infected into 
naive mice. Experimental mice were infected intra-
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Fig, 1. Protection against cerebral malaria in thym cctom ized (Tx) versus in tact mice and in re la tion  to t re a tm e n t w ith
anti-C D 4 o r  an ti-C D 8 mAbs 2 days before and 2 days after infection. C57B1/6J infected w ith  Plasm odium  berghei 
K173 ( T )  or with A N K A  ( # ) ;  C57B1/10 infected with P . berghei K173 ( ■ ) .  T h e  n u m b e r  of m ice  p ro tec ted  against 
CM  versus the total num ber of infected mice is indicated for each experim ental group.
majority of cases > 3 2  °C) survive this critical period 
but die in the third week or later after infection
peritoneally with 103 PE from blood of infected Mice that show a transient hypothermia (in the 
donor animals of the same strain. P. berghei ANKA  
(originally obtained from Dr B. Mons, Laboratory
of Parasitology, University of Leiden, The Nether- without any noticeable cerebral pathology, 
lands) is a gametocyte-producing strain which is 
passaged through Anopheles gambiae mosquitoes 
after 4 weekly blood passages. For this purpose
Body temperature
mosquitoes are allowed to feed on mice 3 days after Body temperature was measured with a digital
infection with 107 parasites. Blood-fed mosquitoes 
received an additional bloodmeal containing normal 
erythrocytes 5 days later and were allowed to infect 
mice 14 days later.
thermometer (Technoterm 1200) introduced into 
the rectum and read after 10 sec.
Parasitaemia
Histology
Mice were killed by an overdose of ether and their 
brains were collected or they were collected post- 
Thin blood films were made from tail-blood, stained mortem. Brain tissue was fixed in Carnoy’s fluid for 
with May-Griinwald and Giemsa’s solutions, and 4 h. Paraffin sections (5 ¡ivci) were stained with  
the proportion of red blood cells infected with the PAS/Haematoxylin or Goldner’s trichrome stain, 
parasite was determined. Sections were scored for the presence of petechiae.
Detection of cerebral malaria
Approximately 95 % of C57B1 mice infected with 103 
P. berghei K173 (Curfs et al. 1992) or P. berghei 
ANKA parasites die early in the second week after 
infection. Approximately 1 day before death a 
progressive hypothermia develops which is strongly 
correlated with development of haemorrhages in the 
brains as observed by histology (Curfs et al. 1989).
In vivo C D 4+ or C D 8 + T-cell depletion
Rat monoclonal anti-CD4 and anti-C D 8 antibodies 
were produced by hybridoma Y T S 191.1.2, EC ACC  
no. 87072282 and Y TS 169.4.2.1, ECACC no. 
87072283 respectively. Both mAbs are of the IgG2b  
isotype. Pristane-primed nude mice were injected 
Lp. with 3 x 106 hybridoma cells and the ascites 
produced was collected. After ammonium sulfate
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Table 1. Effect of treatment with anti-CD4 or 
anti-C D 8 mAbs before and during infection with 
Plasmodium berghei K173 parasites on development 
of cerebral malaria in C57B1 mice
T r e a tm e n t /  
day(s) of 
t re a tm e n t*
M ice  p ro tec ted  against 
C M -tre a te d  m ice
n (% )
C o n tro l 9 /7 8 f 12
Ig G 2 b -c o n tro ls J
- 2 / 2 0 /5 0
9 1 /7 14
A n t i -C D 4
- 2 / 2 3 9 /4 9 1 80
4 3 /3 100
6 3 /3 100
8 7 /8 88
8 +  10 5 /5 100
A n t i - C D 8
- 2 / 2 3 3 /3 6 f 92
4 3 /3 100
6 2 /3 66
8 5 /8 63
8 +  10 5 /5 100
# In  re la tion  to in fec tion  at day 0.
f  S u m m a riz e d  da ta  f ro m  P .  berghei K 173 or P .  berghei 
A N K A -in fe c te d  m ice  (see Fig. 1).
% I so ty p e -m a tc h e d  irre levan t m A b  as a contro l o f m A b  
a n t i -C D 4  o r  a n t i - C D 8 trea tm en t.
(45 %) precipitation and dialysis against H 20 ,  the 
solution was freeze-dried and stored at 4 °C until 
used. Aliquots were solubilized in sterile, pyrogen- 
free saline and used immediately. Normal and 
thymectomized mice were treated once or twice 
(4 days apart) by i.p. injection of 0*3 mg of either 
anti-C D 4 or anti-C D 8 mAb. Treatment with an 
irrelevant isotype matched, ammonium sulfate pre­
cipitated rat mAb was used in comparison to 
treatment with normal rat serum as another control. 
Both control treatments did not prevent devel­
opment of CM and did not affect parasitaemia. 
Therefore, both control treatments were used in the 
C D 4+/C D 8 + T -cell depletion experiments. The  
efficacy of T -cell depletion was determined in 
peripheral leucocytes isolated by water shock-treated 
peripheral blood, or in ACT-treated spleen cell 
suspensions from samples collected 3 days after 
treatment with the anti-T-cell mAbs (Hudson & 
Hay, 1989), Analysis of C D 4+/C D 8 + T -cell de­
pletion immediately after injection of the mAbs was 
complicated by the presence of the injected mAb 
coating the C D 4+/C D 8 + T-cells in the cell sus­
pensions, a problem that was absent when the 
analysis was performed 3 days after the last anti-T- 
cell treatment, Cell suspensions were incubated in 
PBS containing 10 % FCS, 0’05 % sodium azide and 
0-05 m g/m l of the anti-CD4 or anti-C D 8 mAbs for 
30 min at 4 °C followed by a 30 min incubation of a 
50 times diluted FITC-labelled rabbit anti-rat Ig
(Dako) in PBS containing 40% mouse serum and 
0-05% sodium azide. After washing with PBS +  
0’05 % sodium azide fluorescence was read m icro­
scopically.
From the peripheral blood and the spleen respect­
ively 80% and 92% of CD4+ and 62%  and 79%
of C D 8'h T-cells were depleted. Treatment with  
either anti-CD4 or anti-CD8 mAbs did not change 
significantly the proportion of B-cells (data not 
shown).
Protection against cerebral malaria was indepen­
dent of i.v. or i.p. injection of the anti-T-cell m Abs 
(data not shown), and i.p. injections were used for all 
experiments.
Thymectomy
Thymectomy (Tx) was performed on mice anaes­
thetized with chloralhydrate (4*5 % solution; 10 /¿1/g 
body weight). Mice were allowed to recover from  
surgery for a period of 2 weeks before they were used 
in experiments.
Statistica l analysis
For statistical analysis the Student’s i-test (com ­
parison of 2 groups) and the Kruskal-Wallis test 
(comparison of more than 2 groups) were used. P  
values <  0*05 were considered significant.
R E S U L T S
The effect of treatment with anti-CD4 or an ti-C D 8 
mAbs on development of experimental cerebral 
malaria was analysed in thymectomized and intact
C57B1/6J and C57B1/10 mice infected with P. 
berghei A N K A  or P. berghei K173 parasites. Fig. 1 
shows that treatment with anti-CD4 or a n d -C D 8 
mAbs protected against CM, irrespective of thy­
mectomy in both C57B1/6J or C57B1/10 mice 
infected with either P. berghei K173 or P. berghei 
A N K A  parasites.
Parasitaemia in .control mice that died of CM  was 
approximately 5-10%  with a reduction of the 
haematocrit of approximately 20%. Neither th y ­
mectomy, nor treatment with anti-CD4 or an ti-C D 8 
mAbs significantly changed parasitaemia and haem ­
atocrit during infection as compared to controls. All 
treated mice that did not die of cerebral malaria 
developed the same severe anaemia in the course of 
the infection (data not shown). Treatment with  
either an isotype-matched rat mAb or normal rat 
serum as a control for depletion of C D 4+ or C D 8+ T -  
cells by specific rat mAbs had no effect on 
development of CM (Table 1) and did not change 
parasitaemia.
The data in Table 1 show that treatment with anti- 
CD4 or anti-CD8 mAbs 2 days before and 2 days
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Fig. 2. The effect on body temperature of treatment with anti-CD4 or anti-CD8 mAbs 2 days before and 2 days after 
Plasmodium berghei K173 infection in C57B1/6J mice. ( • )  Control mice; (O) anti-CD4 treated mice; (□ )  anti-CD8
treated mice (n — 5).
Table 2 . Effect of treatment with anti-CD4 and/or anti-CD8 mAbs or 
chloroquine on development of cerebral malaria in C57B1/6J mice 
infected with Plasmodium berghei K173 parasites
T reatm ent*
Infected mice 
C M  pro tec ted /to ta l
C M  pro tec ted  m ice  
increased T  °C -|7 to tal
n (% ) n (% )
Saline 2 /52 4 1 /2 50
ChloroquineJ 0 /1 0 0 N .S .
A nti-C D 4 12/17 71 1 1 /1 2 92
A nti-C D 8 1 0 /2 0 50 9 /1 0 90
A n ti-C D 4 + a n ti-C D 8 7 /8 88 I p 100
* T rea tm en t was given when the body tem pera tu re  was betw een 35*5 an d  30*0 °C. 
f  Mice with a statistically significant increase of th e ir  body te m p e ra tu re  a t 24 h  
after treatment.
X Chloroquine trea tm ent: 0*8 m g i.p. m ouse /day .
N .S .,  N o survivors.
after infection protected 80 % and 92 % respectively 
of the mice, whereas 1 2 % of the control mice were 
protected. Moreover, T-cell depletion during in-* 
fection and even when performed on day 8 , i.e. 
shortly before expected death as observed in non­
depleted controls, effectively prevented development 
of the fatal syndrome (Table 1).
The effect on body temperature of treatment with 
anti-CD4 or anti-CD8 mAbs 2 days before and 2 
days after infection with P . berghei K \ 7  2 in CS7B1/6J
mice was analysed in 8 independent experiments. 
The results of 1 representative experiment are 
depicted in Fig. 2. Body temperature of untreated 
infected mice dramatically decreased after 9 days of
infection. Anti-CD4 or anti-C D 8 -treated mice 
showed a limited decrease of their body temperature 
which stabilized. The same effect on body tem ­
perature was found when treatment with anti-CD4  
or anti~CD8 mAbs was given as a single treatment 
up to day 8 of infection (results not shown). Anti- 
C D 8 treatment 2 days before and 2 days after 
infection prevented development of CM as effective 
as CD4+ T-cell depletion (Table 1) and no significant 
difference in body temperature during infection of 
the anti-CD4 and anti-CD8 treated mice was found 
(Fig. 2).
To determine further the latest possible moment 
for effective anti-CD4 or anti-C D 8 treatment in the
Prevention of murine cerebral malaria by anti-CD4 or anti-CD8 11
course of infection, mice were selected with a body 
temperature between 35*5 and 30 °C. If left untreated 
such infected mice died within 24 h as shown in Fig. 
2. The results in Table 2 show that mice with such 
a hypothermia could be protected against fatal 
cerebral malaria by treatment with anti-CD4 and/or 
anti-CD8 antibodies, whereas chloroquine treatment 
could not save any of these mice. No relation could 
be found between body temperature at the moment 
of anti-T-cell treatment (30—35'5 °C) and protection 
against fatal cerebral malaria (data not shown). Anti- 
CD4 or anti-CD8 treatment of mice with a body 
temperature below 30 °C never prevented death. 
Treatment with anti-CD4+ or anti-CD8+ mAbs in 
mice with end-stage disease did not protect all mice 
from the cerebral syndrome (Table 2). These last 
two observations were probably due to petechiae 
that already developed before treatment (Polder e t
a l. 1988).
Depletions that prevented further development of 
the cerebral syndrome also resulted in a subsequent 
increase in body temperature (Table 2). Overall in 
93% (27/29) of the anti-T-cell treated mice body 
temperature increased within 24 h and prevented 
further development of the cerebral syndrome.
D I S C U S S I O N
These studies demonstrate the importance of CD4+ 
and CD8+ T-cells in the pathogenesis of murine 
cerebral malaria (CM), and this was independent of 
the use of C57B1/6J or C57B1/10 mice, or infection 
with P .  b ergh e i  K173 or P. bergh ei  ANKA parasites. 
Thymectomized mice were used to prevent the 
influx of new T-cells after treatment with anti-T-cell 
mAbs, but no significant difference was found when 
data were compared to intact mice. Treatment with 
anti-T-cell mAbs did not completely eliminate all 
CD4+ or all CD8+ T-cells. Together these obser­
vations suggest that complete absence of CD4+ or 
CD8+ T-cells is not necessary to prevent devel­
opment of murine CM. Anti-CD4+ or anti-CD8+ T- 
cell treatment had no effect on parasitaemia and 
development of anaemia confirming the observations 
made by Grau e t  a l. (1986) in another murine P. 
bergh e i  CM model and by Imai & Kamiyama (1994) 
in a rat P. b ergh e i  NK 65 CM model.
The observation that both anti-CD4+ and anti- 
CD8+ T-cell depletion can prevent CM is in 
contrast to observations made previously by Grau et 
al. (1986), who described a role for CD4+ but not 
CD8+ T-cells in development of CM in P. berghei  
ANKA-infected CBA mice. In contrast, Waki e t  a l.  
(1992) and Imai & Kamiyama (1994) found a role 
for CD8+ but not CD4+ T-cells in preventing either 
early mortality or CM, respectively, in P. bergh ei  
NK65-infected rodents. A role for both CD4+ and 
CD8+ T-cells in development of CM in P. bergh ei  
ANKA-infected mice was noted by Weidanz and
collaborators using various types of knock-out mice 
(personal communication). Hancock e t  a l .  (1994) 
found that treatment with anti-CD4 antibodies not 
only depletes CD4-positive T-cells but also CD4-
positive mononuclear cells; however, their possible 
role in CM remains to be determined.
In contrast to our results Grau e t  a l .  (1986) found 
that CD8+ T-cell depletion did not prevent de­
velopment of CM in P. b e r g h e i  ANKA-infected 
CBA mice. This apparent discrepancy may relate to 
different mouse strains used and/or a difference in 
the strain of P. b e r g h e i  ANKA.
Anti-CD4 or anti-CD8 T-cell treatment was 
effective even in mice with end-stage disease (body 
temperature between 35*5 and 30 °C). Histological 
analysis of brains of mice developing the cerebral 
syndrome showed that white blood cells adhere to 
the endothelial lining (Curfs e t  a l .  1989; Polder e t  a l .  
1992) suggesting that these CD4+ and CD8+ T-cells 
are involved in disturbance of the endothelial lining 
and thereby in the functioning of the blood-brain 
barrier.
Disturbance of the blood—brain barrier in mice 
developing CM was also observed by Thumwood e t  
a l,  (1988) and Neill & Hunt (1992). They described
leakage of Evans blue from the vasculature into brain 
parenchyma. In addition, P. b e r g h e i  K173-infected 
mice with end-stage disease are sensitive to de­
velopment of folic acid-induced convulsions, while 
control mice are not. Treatment with anti-CD4+ or 
anti-CD8+ mAbs not only prevents CM but suc­
cessfully treated mice also recover from their 
sensitivity to folic acid-induced convulsions within
4 h after mAb treatment (C. Hermsen e t  a l . 9 unpub­
lished observations). In human cerebral malaria 
convulsions are common (Waruiru e t  a l .  1996), 
raising the question as to whether in human CM 
adherence of sequestered infected red blood cells and 
possibly the presence of leucocytes (Polder, 1989; 
Porta e t  a l . 1993; Eling & Kremsner, 1994; Patnaik 
e t  a L  1994; Eling & Sauerwein, 1995) are involved in 
excessive activation of endothelial cells and sub­
sequent disturbance of the function of the blood- 
brain barrier.
Chloroquine treatment could not save mice in 
end-stage disease while anti-CD4 or anti-CD8 
treatment was still effective. This may be explained 
by the fact that chloroquine like most other anti- 
malarial drugs needs more than 1 day to suppress 
parasitaemia effectively, whereas most of the mice in 
end-stage disease die within 1 day.
Our data are compatible with the hypothesis that 
a localized inflammatory reaction involving both 
CD4+ and CD8+ T-cells disturbs and damages theV J
endothelial lining of the blood-brain barrier eventu­
ally leading to petechiae. Our data suggest that both 
CD4+ and CD8+ T-cells are involved in stimulation 
of a downstream process of the development of the 
petechiae.
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